.png "car tcel")
NewYork-Presbyterian/Columbia has an onsite, in-house Cellular Immunotherapy Laboratory, where our scientists can develop our own cellular therapies quickly, efficiently, and effectively, based on the newest research. Learn More About Clinical Trials at the HICCC
Our researchers and physicians are leading clinical trials for CAR T-cell and other cell therapies so that we can offer this revolutionary treatment to patients with many different cancer types. We're leading the way with new treatments. CAR T-cell therapy is a revolutionary way to treat cancer, and our physicians and researchers are dedicated to advancing the field and finding new ways to help people with other types of cancer and other diseases. Our team also leads research into continuously improving the safety and effectiveness of CAR T-cell therapy and minimizing side effects so you can focus on healing. They also have a great deal of experience caring for patients with multiple health problems and complex medical needs and work closely with teams in the intensive care unit and neurology services to provide optimal care for CAR T patients.
#Car tcel how to#
They know how to give CAR T cells safely and manage any complications or side effects that may arise. Our CAR T-cell team has years of experience administering this treatment and are leaders in the field. Our bone marrow and stem cell transplantation programs are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), and our team performs a large number of transplants and cell therapy procedures each year.Įxperience and safety go hand-in-hand. You'll have your own team of experts. In addition to your stellar team of physicians, nurses, and nurse practitioners with expertise in cancer care, you will have access to a wide range of other specialists that will help you through your CAR T-cell treatment process. CAR stands for "chimeric antigen receptor." In CAR T-cell therapy, our specialized teams collect T cells from the patient and engineer them to express the CAR, turning these cells into ‘serial killers’ that seek and destroy cancer cells.ĬAR-T cell therapy is a powerful new tool for clinicians and researchers at the HICCC in the fight against cancer. CAR T-cell therapy is a type of immunotherapy that trains the immune system to attack cancer with a patient’s own T-cells, a type of white blood cell.
0 kommentar(er)
